Live website intelligence
Patient Information | CAPLYTA® (lumateperone)
Explore how CAPLYTA may help with depressive episodes in adults with MDD and bipolar I & II depression. See if you
Last refresh
Updated 13d ago
Analyst read
Professional
Detected stack
Quick read
How to read caplyta.com quickly
caplyta.com looks like health & fitness. Traffic estimates are limited, so use the trust and structure modules first. Current AI trust scoring is 15/100.
What to do next
- The stack appears to include React.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
42/56 fields populated (75%)
Providers with missing fields
View field-level status
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 5/5
All expected fields present
files: 3/3
All expected fields present
traffic: 0/10
Missing: monthlyVisits, globalRank, countryRank, bounceRate, avgVisitDuration, pagesPerVisit, topCountry, topRegions, topKeywords, trafficSources
whois: 6/6
All expected fields present
radar: 0/4
Missing: globalRank, rankBucket, categories, sourceTimestamp
ai: 7/7
All expected fields present
Why this module matters
Business signals help answer “is this a real opportunity?”
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
- Trust score and sentiment are your first risk screen.
- Business summary and audience notes speed up qualification.
- Ads and monetization patterns reveal how the site captures value.
Business Intelligence
Business Profile
Caplyta (lumateperone) is a prescription pharmaceutical medication manufactured by Intra-Cellular Therapies, FDA-approved for treating schizophrenia, bipolar depression, and as an add-on treatment for major depressive disorder (MDD). The website serves as a patient and healthcare professional resource for drug information, safety data, and savings programs.
Classification
Trust & Risk
Trust Assessment
Google Ads Transparency
Publisher Monetization
Monetization Signals
AI Visual Analysis
IAB Taxonomy
Business Insights
Business Model
Pharmaceutical/Biotech - Prescription Drug Marketing model detected
Trust Level
Low trust with 15/100 score
Audience
Adults (18+) with diagnosed schizophrenia, bipolar I or II disorder, or major depressive disorder; caregivers; and US-based healthcare professionals prescribing psychiatric medications
Keep exploring
Keep exploring from this report
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.